Sphingolipid metabolic pathway

Sphingolipid metabolic pathway. Ceramide is the central hub of sphingolipid biosynthesis. Ceramide can be formed through de novo synthesis, salvage pathway, or through the hydrolysis of complex sphingolipids (blue). In the de novo synthesis pathway, serine palmitoyl transferase (SPT) condenses L-serine + palmitoyl-CoA to generate 3-ketosphinganine (3-keto-dihydrosphingosine). The enzyme 3-ketosphinganine reductase (3-KDSR) then reduces 3-ketosphinganine to generate sphinganine (dihydrosphingosine), which is then converted to dihydroceramide by (dihydro)ceramide synthases 1–6 (CerS1–6). Dihydroceramide desaturase (DES) catalyzes the formation of ceramide by desaturating dihydroceramide. In the salvage pathway, sphingosine can be converted to ceramide by CerS1–6. Ceramide can also be metabolized by ceramidases (CDases) to generate sphingosine, which is phosphorylated by sphingosine kinases 1 and 2 (SPHK1 and SPHK2) to generate sphingosine-1-phosphate (S1P). In reverse, S1P phosphatases (SGPP) can dephosphorylate S1P to reproduce sphingosine. The irreversible actions of S1P lyase can metabolize S1P to yield ethanolamine 1-phosphate and C16 fatty aldehyde, the sphingolipid metabolic pathway exit point. Ceramide kinase (CERK) can phosphorylate ceramide to generate ceramide-1-phosphate, which can also be used to regenerate ceramide by phosphatidate phosphatase (PAP). In the hydrolysis of complex sphingolipids, sphingomyelin can be generated from ceramide by sphingomyelin synthase (SMS), which allows phosphorylcholine transfer to ceramide from phosphatidylcholine (PC) and releasing diacylglycerol (DAG). In return, sphingomyelinases (SMases) cleave sphingomyelin, leading to the release of phosphocholine and ceramide. Additionally, glucosylceramide synthase (GCS) and ceramide galactosyltransferase (UGT8) generate glucosylceramide and galactosylceramide, respectively, from ceramide. This process is also reversible. Abbreviations: GlcCDase, glucosylceramidase; GCDase, galactosylceramidase; GAL3ST1, galactosylceramide sulfotransferase. The pink coloring indicates bioactive sphingolipids, and the blue coloring indicates complex sphingolipids [47]
Sphingolipid metabolic pathway

Publication

Sphingolipid Signaling and Complement Activation in Glioblastoma: A Promising Avenue for Therapeutic Intervention (2024) Alhaji H. Janneh, et al. Biochem (Basel). 2024 Jun 10;4(2). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates S1P S1P ncbigene_synonym MBTPS1 8720
Homo sapiens Primates SPHK SPHK ncbigene_synonym SPHK1 8877
Homo sapiens Primates SPHK SPHK famplex_relations SPHK2 56848
Homo sapiens Primates SPT SPT ncbigene_synonym AGXT 189
Homo sapiens Primates DES DES ncbigene_symbol DES 1674
Homo sapiens Primates ĊERK CERK ncbigene_symbol CERK 64781
Homo sapiens Primates GCS GCS ncbigene_synonym GCLC 2729
Homo sapiens Primates GCS GCS ncbigene_synonym UGCG 7357
Homo sapiens Primates UGT8 UGT8 ncbigene_symbol UGT8 7368
Homo sapiens Primates GAL3ST1 GAL3ST1 ncbigene_symbol GAL3ST1 9514

Chemical mentions

Word Match MeSH Name ChEBI
Lipids lipids lipids chebi:18059
phosphate Phosphate tetraoxophosphoric acid chebi:26078
S1P S1P (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate chebi:37550
phosphate Phosphate tetraoxophosphoric acid chebi:26078
Sphingosine SPHINGOSINE (2R,3S,4Z)-2-aminooctadec-4-ene-1,3-diol chebi:45719
3-ketosphinganine 3-ketosphinganine 2-amino-1-hydroxyoctadecan-3-one chebi:46966
Sphinganine sphinganine (2S,3R)-1,3-dihydroxyoctadecan-2-aminium chebi:57817
phosphate Phosphate tetraoxophosphoric acid chebi:26078
DES DES 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol chebi:41922
Ceramide ceramide an N-acylsphing-4-enine chebi:52639
Dihydroceramide Dihydroceramide an N-acylsphinganine chebi:31488
Sphingomyelin Sphingomyelin chebi:89491
Glucosylceramide glucosylceramide chebi:195532
Galactosylceramide Galactosylceramide 1-(D-galactosyl)-N-octadecenoylsphingosine chebi:75975
Lactosylceramide lactosylceramide chebi:134507
Sulfatide Sulfatide N-{(2S,3R,4E)-3-hydroxy-1-(3-O-sulfo-beta-D-galactopyranosyloxy)octadec-4-en-2-yl}alkanamide chebi:18318
Glycosphingolipids glycosphingolipids chebi:24402

Disease mentions

Word Match MeSH Name DOID